Evozac capsules 30mg from Alfresa Pharma (YJ code: 2399012M1026, 30mg 1 capsule) contain cevimeline hydrochloride hydrate, a cholinergic agonist. It is prescribed to treat dry mouth (xerostomia) symptoms in patients with Sjögren’s syndrome by increasing saliva production.
Evozac capsules 30mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →